General Electric is digging deeper into biotechnology with plans to build four prefabricated drug factories in Ireland, bringing to Europe a low-cost manufacturing concept it first pioneered in China. The new factories on the site will be owned and run by GE customers. The GE BioPark Cork site is expected to create 500 jobs when fully operational, in a boost for Ireland, whose low tax rates have helped it attract hi-tech companies – also sparking an angry row with Brussels in the case of Apple .
See the original post:
GE brings off-the-shelf biotech drug factories to Ireland